Search Results - "Hubalewska-Dydejczyk, Alicja"

Improving the Somatostatin Receptor Status Assessment for Personalized and Precise Management of Neuroendocrine Neoplasms with the Use of a ^99mTc-Radiolabeled Somatostatin Receptor Antagonist: The Final Results of the ERA PerMed TECANT Clinical Trial

Authors: Hubalewska-Dydejczyk, Alicja Decristoforo, Clemens Mikolajczak, Renata et al.

Source: Journal of Nuclear Medicine. Jun2026, Vol. 67 Issue 6, p895-902. 8p.

Serum Concentrations of Selected Biological Factors as a Potential Tool for Detecting Recurrence in Endocrine Tumors—A Pilot Study.

Authors: Kurzynska, Anna Przybylik-Mazurek, Elwira Morawiec-Slawek, Karolina et al.

Source: Journal of Clinical Medicine. Jun2025, Vol. 14 Issue 11, p3732. 11p.

Comparison of 99mTc radiolabeled somatostatin antagonist with [⁶⁸ Ga]Ga-DOTA-TATE in a patient with advanced neuroendocrine tumor.

Authors: Opalinska, Marta Lezaic, Luka Decristoforo, Clemens et al.

Source: European Journal of Nuclear Medicine & Molecular Imaging. Nov2023, Vol. 50 Issue 13, p4110-4111. 2p.

Predictive value of 68[Ga]Ga-DOTA-TATE PET/CT volumetric parameters in assessing treatment response to long-acting somatostatin analogues in patients with well-differentiated neuroendocrine tumours.

Authors: Morawiec-Sławek, Karolina Opalińska, Marta Lenda-Tracz, Wioletta et al.

Source: EJNMMI Research. 11/13/2024, Vol. 14 Issue 1, p1-12. 12p.

Functional and Morphological Changes in the Visual Pathway in Patients with Graves' Orbitopathy.

Authors: Jagiełło-Korzeniowska, Agnieszka Bałdys-Waligórska, Agata Hubalewska-Dydejczyk, Alicja et al.

Source: Journal of Clinical Medicine. Jul2022, Vol. 11 Issue 14, p4095-4095. 11p.

Factors connected with the female sex seem to play an important role in differentiated thyroid cancer.

Authors: Przybylik-Mazurek, Elwira Hubalewska-Dydejczyk, Alicja Fedorowicz, Anna et al.

Source: Gynecological Endocrinology. Feb2012, Vol. 28 Issue 2, p150-155. 6p.

Factors connected with the female sex seem to play an important role in differentiated thyroid cancer.

Authors: Przybylik-Mazurek, Elwira Hubalewska-Dydejczyk, Alicja Fedorowicz, Anna et al.

Source: Gynecological Endocrinology. Nov2011, Vol. 27 Issue 11, p961-965. 5p.

Whole-Exome Screening and Analysis of Signaling Pathways in Multiple Endocrine Neoplasia Type 1 Patients with Different Outcomes: Insights into Cellular Mechanisms and Possible Functional Implications.

Authors: Skalniak, Anna Trofimiuk-Müldner, Małgorzata Surmiak, Marcin et al.

Source: International Journal of Molecular Sciences. Jan2024, Vol. 25 Issue 2, p1065. 11p.

Ectopic Cushing's Syndrome in Advanced Small-Cell Lung Cancer (SCLC): Clinical Challenges and Therapeutic Insights.

Authors: Gamrat-Żmuda, Aleksandra Minasyan, Mari Wysocki, Piotr J. et al.

Source: Cancers. May2025, Vol. 17 Issue 10, p1611. 16p.

Consolidation with ⁹⁰Y ibritumomab tiuxetan radioimmunotherapy in mantle cell lymphoma patients ineligible for high dose therapy: results of the phase II multicentre Polish Lymphoma Research Group trial, after 8-year long follow-up.

Authors: Jurczak, Wojciech Gruszka, Alicja M. Sowa Staszczak, Anna et al.

Source: Leukemia & Lymphoma. Nov2019, Vol. 60 Issue 11, p2689-2696. 8p.

Iodine prophylaxis—the protective factor against stomach cancer in iodine deficient areas.

Authors: Gołkowski, Filip Szybiński, Zbigniew Rachtan, Jadwiga et al.

Source: European Journal of Nutrition. Aug2007, Vol. 46 Issue 5, p251-256.

Development of the 99m Tc-Labelled SST 2 Antagonist TECANT-1 for a First-in-Man Multicentre Clinical Study.

Authors: Novak, Doroteja Janota, Barbara Hörmann, Anton Amadeus et al.

Source: Pharmaceutics. Mar2023, Vol. 15 Issue 3, p885. 16p.

Prevalence of Selected Single-Nucleotide Variants in Patients with Neuroendocrine Tumors—Potential Clinical Relevance.

Authors: Kurzyńska, Anna Pach, Dorota Skalniak, Anna Elżbieta et al.

Source: Journal of Clinical Medicine. Oct2022, Vol. 11 Issue 19, p5536. 9p.

Additional Value of [18F]FDG PET/CT in Detection of Suspected Malignancy in Patients with Paraneoplastic Neurological Syndromes Having Negative Results of Conventional Radiological Imaging.

Authors: Opalińska, Marta Sowa-Staszczak, Anna Wężyk, Kamil et al.

Source: Journal of Clinical Medicine. Mar2022, Vol. 11 Issue 6, p1537-N.PAG. 9p.

Positron emission tomography (PET) in oncology: current applications and future perspectives.

Authors: Trofimiuk-Müldner, Małgorzata Hubalewska-Dydejczyk, Alicja

Source: Bio-Algorithms & Med-Systems. Mar2014, Vol. 10 Issue 1, p47-52. 6p.

Comparison of PET/CT imaging with [18F]FDOPA and cholecystokinin-2 receptor targeting [68Ga]Ga-DOTA-MGS5 in a patient with advanced medullary thyroid carcinoma.

Authors: Uprimny, Christian von Guggenberg, Elisabeth Svirydenka, Anna et al.

Source: European Journal of Nuclear Medicine & Molecular Imaging. Mar2021, Vol. 48 Issue 3, p935-936. 2p. 1 Color Photograph.

The effectiveness of a community-based, type 2 diabetes prevention programme on health-related quality of life. The DE-PLAN study.

Authors: Karamanakos, Georgios Costa-Pinel, Bernardo Gilis-Januszewska, Aleksandra et al.

Source: PLoS ONE. 10/11/2019, Vol. 14 Issue 10, p1-17. 17p.

Comment on: Somatostatin receptor SPECT.

Authors: Hubalewska-Dydejczyk, Alicja Sowa-Staszczak, Anna Tomaszuk, Monika

Source: European Journal of Nuclear Medicine & Molecular Imaging. Oct2012, Vol. 39 Issue 10, p1656-1657. 2p.

A note from the lighthouse.

Authors: Carrió, Ignasi¹ icarrio@hsp.santpau.es

Source: European Journal of Nuclear Medicine & Molecular Imaging. Dec2006, Vol. 33 Issue 12, p1381-1383. 3p. 1 Chart.

Peptide receptor radionuclide therapy as a tool for the treatment of severe hypoglycemia in patients with primary inoperable insulinoma.

Authors: Opalińska, Marta Sowa-Staszczak, Anna Al Maraih, Ibraheem et al.

Source: Bio-Algorithms & Med-Systems. Dec2021, Vol. 17 Issue 4, p221-226. 6p.